Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. de La Camara, R.
  4. Tridello, G.
  5. Ortiz-Maldonado, V.
  6. Urbano-Ispizua, A.
  7. Barba, P.
  8. Kwon, M.
  9. Caballero, D.
  10. Sesques, P.
  11. Bachy, E.
  12. Di Blasi, R.
  13. Thieblemont, C.
  14. Calkoen, F.
  15. Mutsaers, P.
  16. Maertens, J.
  17. Giannoni, L.
  18. Nicholson, E.
  19. Collin, M.
  20. Vaz, C.P.
  21. Metafuni, E.
  22. Martinez-Lopez, J.
  23. Dignan, F.L.
  24. Ribera, J.-M.
  25. Nagler, A.
  26. Folber, F.
  27. Sanderson, R.
  28. Bloor, A.
  29. Ciceri, F.
  30. Knelange, N.
  31. Ayuk, F.
  32. Kroger, N.
  33. Kersten, M.J.
  34. Mielke, S.
  35. Erakutsi egile guztiak +
Aldizkaria:
Leukemia

ISSN: 1476-5551,  0887-6924

Argitalpen urtea: 2021

Alea: 35

Zenbakia: 12

Orrialdeak: 3585-3588

Mota: Artikulua

DOI: 10.1038/S41375-021-01466-0 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus